Ebolavirus is an enveloped virus causing severe hemorrhagic fever. Its surface glycoproteins undergo proteolytic cleavage and rearrangements to permit membrane fusion and cell entry. Here we focus on the glycoprotein's internal fusion loop (FL), critical for lowpH-triggered fusion in the endosome. Alanine mutations at L529 and I544 and particularly the L529 I544 double mutation compromised viral entry and fusion. The nuclear magnetic resonance (NMR) structures of the I544A and L529A I544A mutants in lipid environments showed significant disruption of a three-residue scaffold that is required for the formation of a consolidated fusogenic hydrophobic surface at the tip of the FL. Biophysical experiments and molecular simulation revealed the position of the wild-type (WT) FL in membranes and showed the inability of the inactive double mutant to reach this position. Consolidation of hydrophobic residues at the tip of FLs may be a common requirement for internal FLs of class I, II, and III fusion proteins.
E
bolavirus (Ebov) is a filovirus that causes severe hemorrhagic fever with mortality rates of between 25 and 90% (1, 2) . Outbreaks involving human fatalities have occurred in sub-Saharan Africa since 1976, the last three being in Uganda and the Democratic Republic of the Congo in 2012 and in Guinea and Liberia in 2014 (3) . Ebolavirus is also a much feared potential agent of bioterrorism. However, there are still no FDA-approved treatments or vaccines for this devastatingly morbid infectious agent. One area of therapeutic interest is to target the viral entry machinery that governs virus-host membrane fusion. This would halt infection before initiation of viral replication and subsequent cell destruction. To guide therapeutic design, a detailed knowledge of Ebov entry and membrane fusion is needed, and currently little is known about Ebov virus-host membrane interactions.
Entry of Ebov is mediated by glycoprotein (GP) spikes that protrude from the virus particle (4) (5) (6) (7) (8) . Like most other class I viral fusion proteins, GP is composed of a receptor binding unit (GP1) and a fusion (GP2) subunit. After binding to cell surface receptors, GP mediates virus uptake through a macropinocytosis-like process (9, 10) . Viral fusion ultimately occurs in endosomes, where GP1 is cleaved by cathepsins B and L to an ϳ19-kDa species (11, 12) , which engages Niemann-Pick C1, a late endosomal protein essential for Ebov entry (13) (14) (15) . A final unknown trigger causes conformational changes in GP (16, 17) that expose the fusion loop (FL) in GP2. The Ebov FL is clamped by a disulfide bond and has a hydrophobic region at its tip. It is thought to be functionally equivalent to the linear hydrophobic and glycine-rich fusion peptides found at the N termini of most other class I fusion proteins (18) (19) (20) (21) (22) .
It is clear that the unique internal fusion loop is critically involved in mediating fusion of Ebov with late endosomes, but we do not fully understand which specific protein-lipid interactions give rise to this activity. In pursuit of this question, we previously determined two solution nuclear magnetic resonance (NMR) structures of the FL in a membrane mimetic (20) . One was determined at low pH (similar to endosomal conditions) and represents the active conformation. The other structure was determined at neutral pH and represents a fusion-incompetent state. In the fusion-competent state, the hydrophobic residues of the FL form a structure that resembles a hydrophobic "fist" that we hypothesized to be the membrane-penetrating entity of the FL.
Here we report evidence that the Ebov FL fist is, indeed, required for virus entry and is the portion of the FL that embeds in the target membrane. Through analysis of our previous structures, we identified FL residues likely critical for function and tested them using alanine mutants and liposome fusion assays. We then verified the functional importance of these residues to cell entry using virus-like particles (VLPs) in cell culture. We determined the NMR structures of the most debilitated FL mutants (with mutations I544A and L529A I544A) at pH 5.5 and compared them to the wild-type (WT) structure at pH 5.5. The single mutation at 544 and double mutations both severely disrupted the hydrophobic surface associated with the critical fist structure, which is supported by a scaffold formed among residues L529, F535, and I544. These residues appear to interact in a hierarchical order to form the required hydrophobic surface. Additional biophysical and computational studies further revealed how the fusion loop inserts into lipid bilayers to induce fusion, explaining why this activity is disrupted by the single and double mutations.
MATERIALS AND METHODS
Lipids and detergents. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-(1-phosphoglycerol) (POPG), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-DOPE), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rh-DOPE), 1-palmitoyl-2-(6,7-dibromo)stearoyl-sn-glycero-3-phosphocholine (6,7-Br PC), 1-palmitoyl-2-(9,10-dibromo)stearoyl-sn-glycero-3-phosphocholine (9,10-Br PC), and 1-palmitoyl-2-(11,12-dibromo)stearoyl-snglycero-3-phosphocholine (11,12-Br PC) were purchased from Avanti Polar Lipids. Dodecylphosphocholine (DPC) was purchased from Anatrace.
Site-directed mutagenesis of Ebov FL. Mutants were prepared using site-directed mutagenesis on the WT Ebov FL, which was cloned into a pET-41 vector containing a T7 promoter and kanamycin resistance. Primers were designed to make the described Ala and single Trp mutants and the combination mutants. Stratagene QuikChange site-directed mutagenesis kit 200518 was used to make point mutations to the wild-type Ebov FL.
Site-directed mutations of membrane-anchored trimeric GP1/GP2. The following primers were designed to mutate residues L529 and I544 to alanine: L529A Forward (G GAT GAA GGT GCT GCA ATC GGA GCG GCC TGG ATA CC) and I544A Forward (GCA GCC GAG GGA ATT TAC GCA GAG GGG CTA ATG C; underlined letters represent mutant codons). PfuUltra high-fidelity (HF) DNA polymerase (Agilent 600380-51) was used to make point mutations in a trimeric GP (WT) mammalian expression vector. Maxipreparations (maxipreps) of the sequence-confirmed DNA were then prepared using an Invitrogen HiPure plasmid maxiprep kit (K210007).
Expression and purification of Ebov FL. The Ebov FL WT and its mutants were expressed and purified as previously described, with several modifications (20) . Cell cultures grown at 37°C were induced with IPTG (isopropyl-␤-D-thiogalactopyranoside) at an A 600 of 0.7 to 0.9 optical density (OD) units, and expression was conducted at 30°C for 2 to 4 h. ␤-Mercaptoethanol was removed from the digestion buffer to increase the efficiency of His tag cleavage by factor Xa.
Production and purification of Ebolavirus VLPs. Virus-like particles (VLPs) were produced essentially as previously described (23) . In brief, HEK293T cells were plated and allowed to grow until the cells were 70 to 80% confluent. A mixture of ␤-lactamase-VP40, Cherry-VP40, VP-40, and GP delta WT, L529A, I544A, or L529A I544A DNA was incubated with polyethylenimine (PEI) (Polysciences, Inc.) and added to the cells. After incubation at 37°C for 48 h, the media were harvested and cleared of cell debris via centrifugation. Cleared media were overlaid onto a 20% sucrose cushion and ultracentrifuged. Pellets were resuspended and stored at Ϫ80°C. Samples were analyzed on Western blots probed with anti-Ebov GP and anti-Ebov VP40 antibodies, followed by appropriate secondary antibodies. Blots were then imaged on an Odyssey infrared imaging system (LI-COR) and analyzed for ratios of GP to VP40 using Odyssey software v3.0.
Fluorescence lipid mixing assay. A 96-well plate reader format of the lipid mixing assay was developed from previously described methods (20) . Large unilamellar vesicles (LUVs) composed of POPC-POPG (85:15) were labeled with 1.5 mol% of both Rh-DOPE and NBD-DOPE. Experiments were performed with 100 M lipid and 5 M Ebov FL at pH 7.4 and 5.0. Fluorescence measurements were recorded using a Molecular Devices SpectraMax M5 plate reader fluorometer at room temperature with 1 s of mixing agitation between each scan. Excitation and emission wavelengths were set at 460 nm and 538 nm, respectively. All mutants were normalized to WT lipid mixing values. Experiments were repeated in triplicate for all FLs with at least two different sets of liposome preparations.
Ebolavirus VLP internalization. VLP internalization assays were performed essentially as described previously (23) . In brief, 10 l of WT or L529A, I544A, and L529A I544A mutant Ebolavirus GP VLPs were bound to confluent CHOK1 cells by low-speed centrifugation and washed on ice. Internalization took place for 1 h at 37°C. One hundred fifty microliters of 0.5% phenol red-free trypsin was added to cells for 30 min, and cells were washed to remove uninternalized VLPs. Cells were then lifted, washed, and analyzed on an LSRFortessa cytometer (Becton, Dickinson flow cytometer) for mCherry fluorescence (representing internalized VLPs). Cells that did not receive any VLPs and were warmed for 1 h were used for gating. All data were analyzed using FlowJo software.
VLP entry assay. VLP entry assays were performed essentially as described previously (23) . Postcentrifugation (described in the section on VLP internalization), VLPs were allowed to enter into cells for 3 h at 37°C. A ␤-lactamase substrate, CCF2-AM (Invitrogen), was added, and cells were incubated in the dark at room temperature for 1 h. The CCF2 solution was then removed, and the cells were washed once and incubated overnight in the dark at room temperature. Cells were lifted, fixed, and analyzed using a FACSCalibur flow cytometer. The shift in fluorescence due to cleavage of the CCF2 substrate in the cell cytoplasm by ␤-lactamase-tagged VP40 was used to measure the extent of entry (24) . Cells treated with CCF2-AM alone were used for gating. All data were analyzed using FlowJo software.
NMR experimental and structure determination. Experiments were performed at 30°C on a Bruker Avance III 600 spectrometer equipped with a cold probe. 15 N-1 H heteronuclear single quantum coherence (HSQC) (25) and aliphatic and aromatic 13 C-1 H HSQC (25, 26) spectra were collected to show N-H and C-H correlations. CBCANH and isocyanic acid (HNCO) (27) experiments were performed to obtain backbone assignments. Side-chain assignments were obtained from CCONH (28) , HCCONH (29) , and HCCH-total correlation spectroscopy (TOCSY) experiments. 15 N-edited nuclear Overhauser effect spectroscopy (NOESY) (30) and aliphatic and aromatic 13 C-edited NOESY (25, 31) with mixing times of 100 ms were used to collect nuclear Overhauser effects (NOEs). Samples contained 600 M protein at pH 5.5 in a solution buffered with 30 mM sodium phosphate and 50 mM NaCl and contained 150 mM d 38 -DPC. Data were processed with NMRPipe (32) and analyzed using Sparky (33) . TALOS Plus (34) was used to calculate the dihedral angle restraints. Cyana (35) was used to calculate the initial structures, followed by calculation of 200 structures with CNS (36) . The 20 conformers with the lowest target function were chosen for representation of the overall structure. Regular secondary structure was determined in MOLMOL by an algorithm utilizing hydrogen-bonding patterns (37) . All structures were rendered using PyMOL as the molecular graphics system (38) .
NMR dynamics. The N heteronuclear NOE data were recorded at 30°C on a Bruker Avance III 600 spectrometer equipped with a cold probe using three-dimensional transverse relaxation optimized spectroscopy (TROSY)-HNCO-based pulse sequences (39) . { 1 H}- 15 N heteronuclear NOE experiments were acquired as two interleaved three-dimensional (3D) spectra (NOE and reference spectra, respectively), with a 5-s saturation delay. Relaxation delay times of 50, 120, 300, 600, 1,000, 1,500, and 3,000 ms and 0, 17, 34, 68, 119, 170, 255, 340, and 511 ms were used in the R1 and R2 experiments, respectively.
ITC. Isothermal titration calorimetry (ITC) measurements were made using a MicroCal VP-isothermal titration calorimeter (MicroCal, Northampton, MA). Small unilamellar vesicles (SUVs) were prepared as previously described (20) Tryptophan quenching experiments. Fluorescence measurements were made in a 384-well plate using a Molecular Devices SpectraMax M5 plate reader. Tryptophan excitation was set to 295 nm, and emission was detected at 330 nm. SUVs were composed of POPC-POPG (85:15) for control samples or POPC-POPG-Br-PC (55:15:30) where the lipids were brominated at the 6,7, 9,10, or 11,12 positions. A 500 M concentration of lipid was incubated with 5 M protein at pH 5.0. Relative intensities at 330 nm were calculated for each bromine position and fit using distribution analysis (41) . A list of sequences for single Trp mutants is shown in Fig. 6c below.
Molecular dynamics simulations.
All atomistic simulations were performed using Gromacs 4.5 (42) and the Charmm36 (43) force field for protein and lipid interactions. Temperature was controlled at 300 K using the velocity-rescaling thermostat (44) , and pressure was maintained at 1 bar using the Parrinello-Rahman barostat (45) . All covalent bonds were constrained using P-LINCS (46), and long-range electrostatics were computed at every step using PME (47) . The lipid bilayer was composed of a 512-lipid patch (POPC-POPG [85:15]). The system included approximately 34,000 TIP3p waters. The program g_membed (48) was used for insertion of the FL into the bilayer. To model a pH of 5.5, residues H516, H549, and E545 were protonated. Docking of the WT structure at pH 5.5 was performed using the best-fit Trp insertion depths (see Table 3 below). Each mutant structure was initially placed in the bilayer via global rigidbody alignment to the WT structure.
Following insertion, each system was energy minimized for 500 steps. Systems were then equilibrated for 40 ns using the Gromacs pull code to maintain residues W518, W531, Y534, and Y543 at their initial distances to the phospholipid head groups and also using local bond restraints (restraining distances for each pair of backbone atoms within 7 Å of each other to their original distance) to maintain the initial structure. Both sets of restraints were then released, and production runs were carried out for Ͼ500 ns in each case. Equilibration and production runs were performed with the same settings for electrostatics and van der Waals (vdW) interactions, using a short-range electrostatic cutoff of 1.2 nm, while vdW interactions were switched off between 0.8 and 1.2 nm. The time step in the atomistic simulations was 2 fs.
Coarse-grained simulations were performed using Gromacs 4.5 and the MARTINI force-field (49, 50) . An initial patch with the same constituents as for the atomistic simulations was produced using the g_fg2cg (51) tool. A coarse-grained representation of the FL was then placed out of the membrane, at a center of mass-distance to the phospholipid head groups of approximately 3 nm. Local structural restraints were put in place to maintain the NMR structure when in solution conditions. Eleven runs of each system (WT and L529A I544A mutant) were completed. Each system was energy minimized as described above. Production runs were carried out for 10 s for each system, using a time step of 20 fs.
Protein structure accession numbers. 
RESULTS
Identification of residues required for liposome fusion and VLP cell entry. Analysis of FLs containing mutations at 13 hydrophobic residues revealed several partially inactive single mutants and one completely inactive double mutant (Fig. 1a and b) . The WT NMR structure showed long-range hydrophobic interactions between residues L529 and I544 (20) that we hypothesized might be defining its structure and hence critical for membrane fusion and cell entry. To test this hypothesis, we focused here on the two partially inactive L529A and I544A mutants and the completely inactive L529A I544A double mutant. Activity of FL mutants was first determined using a liposome-based fluorescence resonance energy transfer (FRET) fusion assay (Fig. 1b) . The results showed that the L529A I544A double mutant was most compromised for FL activity: only 2% of WT lipid mixing activity was observed with this mutant. Mutants with single alanine mutations at L529 and I544 showed 68% and 22% lipid mixing activity, respectively. These mutations were next introduced into a construct encoding transmembrane-anchored GP1/GP2 trimeric spikes and coexpressed with Ebov VP40 in HEK293 cells to form virus-like particles (VLPs) (23) . The GPs containing mutations at 529 and/or 544 were successfully incorporated into VLPs and supported VLP internalization into cells as efficiently as WT GP (Fig. 1d and e) . Nonetheless, as seen in Fig. 1c , the trimeric membrane-anchored GP mutants showed similar defects in supporting VLP entry into the cytosol of target cells (a measure of VLP fusion with late endosomes) as their respective FLs showed for liposome fusion, although the I544A mutant was somewhat more impaired for VLP entry. The W518A FL mutant, which showed significantly impaired lipid mixing (Fig.  1b) , was not further characterized because this mutation perturbed incorporation of GP into VLPs.
Secondary structure analysis of Ebov FL mutants by NMR. To probe for long-range effects of alanine mutations on secondary structure in the FL constructs, we used NMR spectroscopy to gather structural information on each residue in the L529A, I544A, and L529A I544A FLs and compared the data to those for the WT FL. Heteronuclear single quantum correlation (HSQC) spectra at pH 5.5 for the WT and L529A, I544A, and L529A I544A mutants all showed well-dispersed spectra indicative of the presence of well-defined secondary structure (Fig. 2 and Fig. 3) .
The backbone resonances of each mutant, assigned using standard triple resonance techniques on 15 N-and 13 C-labeled samples, showed marked differences in peak position compared to the WT. Chemical shift differences are plotted in Fig.  2c and Fig. 3c and d As expected, significant changes in chemical shift were observed directly around each mutation site. However, changes above 0.2 ppm were also apparent for L529A extending out to Y534, and in the case of I544A, increased chemical shifts were observed down to residue G536. In the double mutant, significant changes were observed for the majority of the residues that compose the primary hydrophobic region (i.e., A525 through A539), as well as the downstream region from I542 to I544, which was previously shown to contribute hydrophobicity to the fist structure (20) .
Solution NMR structure of the I544A and L529A I544A mutants. To further scrutinize the molecular reasons for the moderate and severe fusion and entry defects of the I544A and L529A I544A mutants, we determined their solution NMR structures in the presence of DPC micelles at pH 5.5. To do so, 306 and 447 NOEs, respectively, were collected from 15 N-edited and 13 C-edited NOESY experiments. Structures were calculated using these and additional dihedral angle restraints (Table 1) . Figure 4b and c show the 20 lowest-energy conformers of the I544A and L529A I544A mutants and compare them to the 20 lowest-energy conformers of the WT, which were previously determined in DPC micelles at pH 5.5 ( Fig. 4a) (20) . Complete 15 N relaxation data show that all structures are fairly well ordered throughout the molecules (see the relaxation data in the supplemental material). For example, except for the terminal residues, all { 1 H}- 15 N NOE values are in the range 0.4 to 0.85, reaching their theoretical rigid limit, and most of them are between 0.6 and 0.8, which is typical for lipid micelle-associated proteins and polypeptides (52, 53) . Compared to the WT, the double mutant structure shows a significantly flattened tip and lacks the characteristic 90°bend. The single mutant also lacks the 90 o bend but still shows an interaction between Ala544 and Leu529 (Fig. 4e ) not seen in the double mutant (Fig. 4f) . As predicted from the chemical shift data, there is a significant structural change in the hydrophobic region located at the tip of the FL. A direct comparison of the WT and single and double mutant fusion loop tips is shown face-on in Fig. 4d to f . The double mutant clearly shows a flat elongated tip, where the highlighted residues 529, 535, and 544 are spread out and no longer form the hydrophobic scaffold of residues L529, F535, and A544 that we propose is required for the formation of the fist seen in the WT. As seen in Fig. 4g to i, the hydrophobic residues (in red) are therefore broadly distributed at the face of the double mutant, while they are closely packed at the face of the compact WT structure and intermediate in the single mutant.
Binding and penetration of the Ebov FL into membranes. We next asked whether the fusion and entry defects of the mutants were primarily due to a different strength of membrane binding or a different mode of penetration into the membrane or both. To address the first question, we measured binding of the WT and mutant FLs to liposomes by isothermal titration calorimetry (ITC). ITC binding isotherms are shown in Fig. 5 . The data were analyzed with a partition model as indicated in Materials and Methods, and the resulting apparent partition coefficients are shown in Table 2 . Experiments were performed for the WT, the L529A and I544A single mutants, and the double mutant at pH 5.0 and for the WT at pH 7.4. Binding was not detected for either WT at pH 7.4 or the L529A I544A double mutant at pH 5.0. The apparent partition coefficients were 112,000 M Ϫ1 for the WT but only 30,000 and 5,400 M Ϫ1 , respectively, for the two single mutants at pH 5.0. Thus, the partitioning of these FLs into bilayers was weaker than for the WT following the same trends as seen in the lipid mixing and VLP entry assays.
To measure penetration of the FL into lipid bilayers, we measured the quenching of tryptophan (Trp) residues by membrane-bound brominated lipids (54) . The fusion loop contains two natural Trp residues (Trp518 and -531) and two natural tyrosines (Tyr534 and -543). To separately measure the penetration depth at each of these positions, we made four single Trp mutants. To produce the single Trp518 and Trp531 mutants, residues 531 and 518 were individually converted to phenylalanines. To produce the Trp534 and Trp543 mutants, the two tyrosines were individually converted to Trp residues in a background in which Trp518 and -531 were both mutated to phenylalanines. To ensure that Trp substitutions did not affect function, lipid mixing control experiments were performed for the single Trp mutants in the WT backbone (Fig. 6d) . Analogous single Trp mutants were also made for the L529A, I544A, and L529A I544A mutants. For clarification, the sequences of all 16 FL constructs are shown in Fig. 6c .
Insertion depths of the 16 resulting single Trp mutants were measured via collisional fluorescence quenching with bromine, using liposomes containing bromo-PC substituted with bromines at the acyl chain 6,7 or 9,10 or 11,12 positions and fitting the data by distribution analysis as described in Materials and Methods.
The results for the WT show that residues Trp518 (green symbols) and Trp531 (blue symbols) do not penetrate the bilayer; no significant interaction with the lipid acyl chains was observed (Fig.  6a) . However, Trp534 (cyan line) and Trp543 (red line) showed quenching profiles indicative of acyl chain penetration (Fig. 6a) . Quenching profiles for L529A showed similar results to the WT, where residues 534 and 543 are well associated with the membrane and 518 and 531 are not (Fig. 6b) . We therefore concluded that L529A has comparable FL orientation and membrane insertion to the WT. As expected from the ITC results, no considerable insertion was detected for the I544A or L529A I544A mutant. The maximum likelihood depths of penetration for each single Trp construct for WT and L529A, expressed as distance from the bilayer center or surface, are shown in Table 3 . The most notable differences occur at Trp534 and Trp543: Trp534 and Trp543 were located approximately 7.9 Å and 8.8 Å from the center of the bilayer for the WT and 9.3 Å and 7.9 Å, respectively, for the L529A mutant. Assuming that the thickness of our bilayers is 42 Å (phosphate-to-phosphate distance), Trp534 and Trp543 penetrate the first leaflet of the lipid bilayer approximately 13.1 Å and 12.2 Å for the WT and 11.7 Å and 13.1 Å for the L529A mutant, respectively. Molecular dynamics simulations to dock positions of Ebov FL in lipid bilayers. Molecular dynamics simulations were used to test the physical compatibility of the FL structures determined in micelles with bilayer insertion data as well as the degree to which the hydrophobic fist structure influences membrane interaction. The WT NMR structure at pH 5.5 was docked into a POPC-POPG (85:15) lipid bilayer based on the experimental tryptophan depth approximations (Fig. 6a) , and the I544A and L529A I544A structures were aligned to the docked WT. Each docked structure was then simulated via atomistic molecular dynamics for 500 ns (see Videos S1, S2, and S3 in the supplemental material for the WT, I544A, and L529A I544A simulations, respectively). As shown in the simulation snapshots taken after 400 ns, each mutant stabilized to a slightly different insertion mode (Fig. 7a to c) . The numbers of membrane-inserted residues were not statistically different between the wild-type peptide and the I544A mutant over the 500-ns simulation trajectories, but the wild-type peptide retained its "fist" structure, whereas I544A never assumed such a structure in the unrestrained simulations. The L529A I544A mutant, in contrast, maintained insertion of only a short part of the loop, and the number of inserted residues was significantly fewer than those in either the wild type or the I544A mutant (P Ͻ 10 Ϫ5 via Wilcoxon rank sum test). These simulations were not constrained using the experimental NMR data. Nonetheless, all three molecules maintained their structures throughout the course of the simulation with calculated C ␣ (C 511 to C 556 ) root mean square deviation (RMSD) values of 2.2, 1.7, and 2.6 Å for the WT, I544A mutant, and L529A I544A mutant, respectively. We did not observe gross disruption or curvature induction of the bilayers in these simulations, but we cannot rule out that such effects could happen with much more extensive sampling and additional copies of FLs in the membrane.
Coarse-grained simulations were also conducted where the structures were placed in solution and allowed to interact with a bilayer. In these coarse-grained simulations, each sequence was constrained to hold its respective structure determined via NMR.
The hydrophobic portion of the WT fist structure (A525 to I544) ( Fig. 7d and e) bound and penetrated bilayers more often and more deeply than the corresponding region of the open L529A I544A structure, which associated only minimally with the phospholipid head groups.
DISCUSSION
Virus-host membrane fusion is an essential step in the life cycle of every enveloped virus. One of the first events in initiating membrane fusion is the interaction of viral fusion peptides or fusion loops, found in all viral fusion proteins, with the target membrane. The fusogenic peptide from Ebov is somewhat unique among class I fusion proteins in being an internal loop maintained by a disulfide bond, as opposed to being a more typical N-terminal fusion peptide. To investigate structural properties that are critical for the interaction of the internal Ebov FL with target membranes and their functional consequences, we employed solution NMR, fluorescence spectroscopy, virus-like particle cell entry, calorimetry, and molecular simulation methods. Although membrane interactions of N-terminal short fusion peptides of many viruses have been studied in the past in much detail, the present work represents the first comprehensive investigation of the interaction of a large disulfide-clamped fusion loop with lipid membranes. Using liposome fusion and Ebov GP VLP entry assays, we first identified L529 and I544 as key residues for virus fusion and entry. L529 is located in the previously recognized major hydrophobic region of the FL, while I544 is located in an additional short hydrophobic segment located C terminal to the primary hydrophobic region. These results confirm our hypothesis that L529 and I544 engage in a hydrophobic interaction (hydrophobic bridge) that is critical for the development of the fusion-active hydrophobic surface of the FL. The present study further demonstrates that F535 needs to interact with the hydrophobic bridge to form a hydrophobic triad that supports the bent fist structure of the fully functional fusion loop. The I544A mutant forms a smaller hydrophobic bridge (between A544 and L529), to which F535 no longer binds. Therefore, and the Ebov FL I544A (b) and L529A I544A (c) mutants at pH 5.0, all rendered after 400 ns of simulation. The I544A mutant displayed a "flatter" structure but was still membrane associated, while the L529A I544A mutant was both less structured and significantly less inserted (P Ͻ 10 Ϫ5 ). Coarse-grained simulations show the binding of the WT FL to a lipid bilayer starting from a solution conformation of WT Ebov FL at time 0 (d) to form a membrane-bound structure at 3 s. The hydrophobic region, A525 to I544, is colored green, while the other residues are shown in red for the WT, magenta for the I544A mutant, and blue for the L529A I544A mutant. Phospholipid head groups are in orange, and in atomistic simulations, the first leaflet of the lipid bilayer is shown in a line representation. Movies of atomistic simulations of the WT (Video S1), the I544A mutant (Video S2), and the L529A I544A mutant (Video S3) insertions are shown in the supplemental material.
this mutant no longer forms either the triad or the bent fist. In the double mutant, there is no interaction between residues 529, 535, and 544, and hence, this mutant is severely altered in structure and does not interact with membranes to any significant extent.
Beyond providing proof for the importance of the three-point hydrophobic scaffold in developing the functional fist structure of the Ebov FL, the calorimetric binding and fluorescence-based membrane insertion data show how this structure inserts into lipid bilayers and that the L529-to-I544 plus F535 scaffold is required for the FL to properly bind and penetrate the model membranes. Moreover, the combined insertion and molecular dynamics studies demonstrate that the surface of the WT FL that interacts most extensively with the lipid bilayer is the front face, or tip, of the fist-shaped FL. I527, W531, I532, Y534, F535, I542, and Y543 are consolidated at this tip to form a contiguous hydrophobic surface for membrane insertion.
The hydrophobic scaffold residues L529, F535, and I544 all point inward in the fusion-active WT structure (20) . When I544 or both I544 and L529 were mutated to alanines, the fusion activity of the FL and VLP entry mediated by Ebov GP were both inhibited. While we saw only a minimal effect from mutating F535 to an alanine, we saw a significant effect on function when F535 was mutated to a tryptophan, which is bulkier than phenylalanine. This example shows that the ability to fuse membranes is not simply an effect of the hydrophobicity of individual residues, but some mutations can have long-range effects in these larger FLs with tertiary structure. Mutation of F535 to an arginine was previously shown to significantly reduce GP-mediated virus entry as well as binding of the GP ectodomain to liposomes (16, 21) . Collectively, our findings indicate that the scaffold formed by L529, F535, and I544 is strictly required to form the fist with the consolidated hydrophobic surface at the tip of the FL and that this specific structure is crucial for a sufficiently deep membrane insertion of the FL, as well as its ability to promote membrane fusion and virus entry.
All fusion peptides and fusion loops are thought to function by inserting hydrophobic residues into the lipid bilayer of target membranes. However, the level of hydrophobicity and the distribution of hydrophobic residues needed to create a functional membrane-interacting surface are not known. In Fig. 8 , we compare the structures of several FLs, most derived from the postfusion structures of the corresponding viral fusion proteins. A number of different patterns emerge in terms of distribution of hydrophobic residues on the surfaces of these FLs. In some cases, the hydrophobic residues form consolidated hydrophobic surfaces, as we revealed for the Ebov FL at pH 5.5 in DPC micelles, but in other cases, they are more sparsely distributed. Examples of consolidated hydrophobic surfaces can be found in class I (Ebov) (Fig. 8a) , class II (flaviviruses) (Fig. 8c) , and class III (vesicular stomatitis virus) (Fig. 8b) fusion proteins. On the other hand, some class II (rubella virus) (Fig. 8e ) and class III (baculovirus and herpesviruses) (Fig. 8e to h ) fusion proteins display quite dispersed hydrophobic residues on their FL surfaces, while some class II alphaviruses (Fig. 8d) feature intermediate situations.
Since most of these structures were obtained in the absence of a membrane mimetic, it is possible that further rearrangement of hydrophobic side chains on the surface may take place when these FLs bind to and penetrate membranes. An indication that a consolidation of hydrophobic residues may happen upon lipid binding is given by the comparison of two structures of the Chikungunya virus FL: the residues are more dispersed on the FL in the crystal structure of the full (prefusion) fusion protein without lipids (55) but more consolidated, with clusters of two Phe and two Tyr residues, in an 18-residue peptide analogue inserted into DPC micelles for structure determination by NMR (Fig. 8d) (56) . A similar consolidated hydrophobic grouping formed by Trp, Phe, and Leu residues was observed in the FLs at the tips of class II flavivirus fusion proteins (Fig. 8c) (57-59) .
A consolidated hydrophobic surface may be required for the proper functioning of all FLs. Hence, as we found for the Ebov FL upon exposure to low pH (in a membrane mimetic) (20) , rearrangements of hydrophobic residues have also been proposed (60) and experimentally supported (61, 62) for the fusion loops of the herpes simplex virus gB fusion protein. Similarly, the bipartite FLs from rubella virus E1 are proposed to form, along with an amphipathic ␣-helix, a large membrane-interacting surface, and this consolidation of hydrophobic regions is thought to be crucial for the infectivity of the virus (63) . Alternatively, a greater number of FLs may be required to come together at the site of fusion if viral fusion peptides/loops have more sparsely distributed hydrophobic residues. This may be the case for baculovirus, for which up to 10 trimers of gp64 appear to be required (64) .
Our structures of the Ebov GP2 FL are the first molecular depictions of a large disulfide-clamped FL in a lipid environment. Together with analyses of the structure-disrupting mutations, our findings clearly show that a continuous consolidated hydrophobic surface is necessary to promote fusion of this virus with its target membrane, both in vitro and in vivo. Our findings also indicate that an internal scaffold of three hydrophobic residues is needed to present the consolidated hydrophobic surface to the target membrane. It will be interesting to see whether other viruses have similar strict requirements for surface presentation of hydrophobic residues on their FLs to enable fusion. At least for the case of Ebov GP2, low pH and a lipid interface cooperate to trigger formation of the fusion-active conformation with a sufficiently large exposed hydrophobic surface area. More structural information in appropriate environments is required for other viral fusion proteins before we can determine with certainty which features of FLs are common and required to render them fusogenic. The current work on Ebov GP2 not only represents a major step forward toward a thorough understanding of the structural features of the Ebov FL under fusion-competent conditions but hopefully will also stimulate similar future work on the FLs of other viruses. Such information combined with structural knowledge of the fusion proteins in their prefusion states and pathways to postfusion states, as is emerging for Ebov GP (4, 7, 11, 12, 16) , may facilitate the development of therapeutics aimed against the fusion machinery.
